Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

BUY
$1.22 - $4.83 $2,851 - $11,287
2,337 Added 3.15%
76,573 $94,000
Q2 2023

Aug 04, 2023

BUY
$2.95 - $4.44 $39,211 - $59,016
13,292 Added 21.81%
74,236 $290,000
Q1 2023

Apr 27, 2023

BUY
$2.94 - $4.18 $10,869 - $15,453
3,697 Added 6.46%
60,944 $200,000
Q4 2022

Feb 02, 2023

BUY
$2.73 - $3.7 $7,895 - $10,700
2,892 Added 5.32%
57,247 $166,000
Q3 2022

Nov 04, 2022

BUY
$0.48 - $3.48 $18,830 - $136,523
39,231 Added 259.4%
54,355 $138,000
Q2 2022

Aug 03, 2022

BUY
$2.22 - $4.54 $33,575 - $68,662
15,124 New
15,124 $33,000
Q1 2022

May 02, 2022

SELL
$3.58 - $4.98 $64,035 - $89,077
-17,887 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$4.17 - $7.09 $74,588 - $126,818
17,887 New
17,887 $85,000
Q1 2021

Apr 26, 2021

SELL
$8.26 - $11.4 $102,291 - $141,177
-12,384 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$8.21 - $18.59 $101,672 - $230,218
12,384 New
12,384 $0
Q3 2020

Oct 14, 2020

SELL
$11.33 - $19.81 $5,665 - $9,905
-500 Closed
0 $0
Q2 2020

Jul 13, 2020

SELL
$4.2 - $15.45 $17,161 - $63,128
-4,086 Reduced 89.1%
500 $5,000
Q1 2020

Apr 29, 2020

BUY
$3.38 - $10.63 $15,210 - $47,835
4,500 Added 5232.56%
4,586 $20,000
Q4 2019

Feb 05, 2020

BUY
$5.74 - $7.42 $493 - $638
86 New
86 $0
Q3 2019

Oct 15, 2019

SELL
$4.68 - $7.42 $360 - $571
-77 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$4.67 - $5.88 $359 - $452
77 New
77 $0
Q1 2019

Apr 18, 2019

SELL
$4.19 - $5.25 $419 - $525
-100 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$3.51 - $8.6 $351 - $860
100 New
100 $0

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.